Researchers compared long-term health-related quality of life (QoL) in patients with advanced lung or gastrointestinal cancer after administration of either chemotherapy or placebo, published in The Lancet (online August 21, 2017; doi:10.1016/S1470-2045(17)30471-0).
NEW YORK (Reuters Health) - Video-assisted thoracoscopic (VATS) lobectomy is associated with shorter hospital stay and non-inferior long-term survival in patients with stage 1 non-small-cell lung cancer (NSCLC), compared with open lobectomy, according to findings from the National Cancer Data Base.
Specific gene rearrangements associated with increased resistance to standard therapy may predict different metastasis distributions in patients with non-small cell lung cancer (NSCLC), according to research published in JCO Precision Oncology (online August 16, 2017; doi:10.1200/PO.17.00063).
Two of the most common chemotherapy regimens may be comparable in terms of efficacy when used in combination with radiotherapy for treatment of non-small cell lung cancer (NSCLC), according to a recent study published in JAMA Oncology.
Patients with early stage metastatic non-small cell lung cancer (NSCLC) whose tumors express high levels of PD-L1 have improved quality of life with pembrolizumab treatment versus standard of care platinum-containing chemotherapy, according to new research.
Patients with non-squamous non-small cell lung cancer (NSCLC) have improved progression-free survival (PFS) if they switch from docetaxel to paclitaxel and bevacizumab treatments, according to new research.